USAA
ATRA icon

United Services Automobile Association’s Atara Biotherapeutics ATRA Stock Holding History

United Services Automobile Association’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-300
Closed -$298K – 2240
2019
Q1 		$298K Hold
300
– – ﹤0.01% 1901
2018
Q4 		$261K Sell
300
-33
-10% -$30.6K ﹤0.01% 1884
2018
Q3 		$344K Buy
333
+8
+2% +$7.82K ﹤0.01% 1872
2018
Q2 		$299K Buy
325
+72
+28% +$77.3K ﹤0.01% 1927
2018
Q1 		$247K Buy
+253
New +$231K ﹤0.01% 1986

Other funds holding ATRA

Baupost Group
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Maverick Capital
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

United Services Automobile Association's ATRA Position: Q2 2019 in Review

United Services Automobile Association sold out of Atara Biotherapeutics (ATRA) in Q2 2019, closing a stake of 300 shares — an estimated $298K sold.

United Services Automobile Association first reported a position in ATRA in Q1 2018 and held it in 5 quarters. The position peaked at $344K in Q3 2018. 116 funds tracked by Wall St. Rank hold ATRA as of Q2 2019.

  • United Services Automobile Association reported no remaining Atara Biotherapeutics position as of Q2 2019 after selling out during the quarter.
  • United Services Automobile Association sold 300 Atara Biotherapeutics shares in Q2 2019, an estimated $298K.
  • United Services Automobile Association first reported a position in Atara Biotherapeutics in Q1 2018 and held it in 5 quarters.
  • United Services Automobile Association's Atara Biotherapeutics position peaked at $344K in Q3 2018.
  • 116 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2019.

Based on United Services Automobile Association's 13F filing for Q2 2019, filed 16 Aug 2019.